WO2012066280A2 - Blood analysis apparatus and method - Google Patents

Blood analysis apparatus and method Download PDF

Info

Publication number
WO2012066280A2
WO2012066280A2 PCT/GB2011/001602 GB2011001602W WO2012066280A2 WO 2012066280 A2 WO2012066280 A2 WO 2012066280A2 GB 2011001602 W GB2011001602 W GB 2011001602W WO 2012066280 A2 WO2012066280 A2 WO 2012066280A2
Authority
WO
WIPO (PCT)
Prior art keywords
blood
oxygenator
group
sensor
sensors
Prior art date
Application number
PCT/GB2011/001602
Other languages
French (fr)
Other versions
WO2012066280A3 (en
Inventor
Andrew Ian Hart
Original Assignee
Spectrum Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Medical Ltd filed Critical Spectrum Medical Ltd
Publication of WO2012066280A2 publication Critical patent/WO2012066280A2/en
Publication of WO2012066280A3 publication Critical patent/WO2012066280A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4925Blood measuring blood gas content, e.g. O2, CO2, HCO3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32Oxygenators without membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3623Means for actively controlling temperature of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698Blood oxygenators with or without heat-exchangers

Definitions

  • the present invention relates to a blood analysis apparatus and method.
  • Known blood gas analysers typically provide direct measurements of various properties of the blood, such as pH, partial pressure of oxygen (P02), partial pressure of carbon dioxide (PC02), and oxygen saturation.
  • P02 and PC02 are sometimes known respectively as Pa0 2 and PaC0 2 , or simply Pa02 and PaC02.
  • P02 reflects the amount of oxygen gas dissolved in the blood, and is an indicator of the effectiveness of the lungs in transferring oxygen into the blood stream from the air breathed in. Decreased P02 levels may be associated with anaemia, hypoventilation or pulmonary disease. On the other hand, PC02 reflects the exchange of C0 2 through the lungs to the outside air. Increased levels of PC02 may be caused by pulmonary oedema or lung disease, while decreased levels of PC02 may be caused by hyperventilation or hypoxia.
  • the present applicant has appreciated the desirability of providing an apparatus and method for the indirect and/or non-invasive determination of P02 and PC02, for example during cardiopulmonary bypass surgery or when membrane oxygenation of patients blood is carried out, for example extra-corporeal membrane oxygenation (ECMO) procedures.
  • ECMO extra-corporeal membrane oxygenation
  • a blood analysis apparatus for use in a system in which blood from a patient is provided to an oxygenator and in which blood from the oxygenator is provided back to the patient.
  • a first group of sensors is provided for directly measuring a corresponding first group of properties of the blood provided to or from the oxygenator.
  • a second group of sensors is provided for directly measuring a corresponding second group of properties of a gas provided to or from the oxygenator.
  • a processor is provided for determining a value for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.
  • a blood analysis method Blood is provided from a patient to an oxygenator. Blood is provided from the oxygenator back to the patient. A first group of properties of the blood provided to or from the oxygenator is directly measured using a corresponding first group of sensors. A second group of properties of a gas provided to or from the oxygenator is directly measured using a corresponding second group of sensors. A value is determined for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.
  • At least one of the first group of sensors may be adapted to measure its corresponding property without coming into contact with the blood. It may be that each of the first group of sensors is adapted to measure its corresponding property without coming into contact with the blood.
  • the first group of sensors may comprise a blood temperature sensor for measuring a temperature of the blood provided to or from the oxygenator and a blood flow rate sensor for measuring a flow rate of the blood provided to or from the oxygenator.
  • the second group of sensors may comprise a carbon dioxide out sensor for measuring a concentration of carbon dioxide in the gas provided from the oxygenator.
  • the partial pressure of carbon dioxide in the blood may be determined in dependence upon the measurements of blood temperature, blood flow rate, and concentration of carbon dioxide in the gas provided from the oxygenator.
  • the second group of sensors may comprise an oxygen in sensor for measuring a concentration of oxygen in the gas provided to the oxygenator.
  • the partial pressure of oxygen in the blood may be determined in dependence upon the measurements of blood temperature, blood flow rate, concentration of carbon dioxide in the gas provided from the oxygenator, and concentration of oxygen in the gas provided to the oxygenator.
  • the second group of sensors may comprise a carbon dioxide in sensor for measuring a concentration of carbon dioxide in the gas provided to the oxygenator.
  • the partial pressure may be determined in dependence upon the measurement of concentration of carbon dioxide in the gas provided to the oxygenator.
  • the first group of sensors may comprise one or both of a haemoglobin sensor for measuring a level of haemoglobin in the blood provided to or from the oxygenator and a blood saturation sensor for measuring a level of red blood cell oxygen saturation provided to or from the oxygenator.
  • the partial pressure may be determined in dependence upon the measurement of haemoglobin and/or blood saturation level.
  • the second group of sensors may comprise one or both of a gas temperature sensor for measuring a temperature of the gas provided to or from the oxygenator and a gas flow rate sensor for measuring a gas flow rate of the gas provided to or from the oxygenator.
  • the partial pressure may be determined in dependence upon the measurement of gas temperature and/or flow rate.
  • the blood analysis apparatus may comprise a pressure sensor for measuring atmospheric pressure.
  • the blood analysis method may comprise measuring atmospheric pressure.
  • the partial pressure may be determined in dependence upon the measurement of atmospheric pressure.
  • the pressure sensor may form part of the second group of sensors.
  • the blood analysis apparatus may comprise a second processor for applying a correction to one or more of the measurements of concentration.
  • the blood analysis method may comprise applying a correction to one or more of the measurements of concentration.
  • the partial pressure of oxygen in the blood may be determined according to function (11 ) below.
  • the partial pressure of carbon dioxide in the blood may be determined according to function (12) below.
  • Each of the sensors is adapted to measure its corresponding respective property extracorporeal ⁇ . Therefore, a method and apparatus according to an embodiment of the present invention is intended to be used extra-corporeally, and not directly on the human or animal body.
  • a program for controlling an apparatus to perform a method according to the second aspect of the present invention or which, when loaded into an apparatus, causes the apparatus to become an apparatus according to the first aspect of the present invention may be carried on a carrier medium.
  • the carrier medium may be a storage medium.
  • the carrier medium may be a transmission medium.
  • an apparatus programmed by a program according to the third aspect of the present invention.
  • a storage medium containing a program according to the third aspect of the present invention.
  • FIG. 1 illustrates a system embodying the present invention
  • FIG. 2 illustrates a method embodying the present invention.
  • the aim of an embodiment of the present invention is to determine the levels of P02 and PC02 within the arterial blood stream, and in particular to achieve this by indirect and/or non-invasive means.
  • a first equation of interest is the following for arterial oxygen content (Ca0 2 ):
  • CaQ 2 Hb(gm/dl) ⁇ 34(0 2 /gm)Hb *Sa0 2 +Pa0 2 * 0.003(m/O 2 ImmHgldl)
  • PA0 2 FI0 2 ⁇ BP - 47) - 12PaC0 2
  • FI0 2 is the fraction of inspired oxygen.
  • variables (or properties) that have been identified as being useful are, but are not limited to:
  • Figure 1 illustrates a system embodying the present invention.
  • extra-corporeal blood property measurements are made externally of the patient, typically during a procedure in which the patient's blood is routed through a system such as a heart lung machine during a heart bypass operation.
  • the system comprises a venous blood flow line 20, an arterial blood flow line 30 and an oxygenator 40, for example as part of a heart-lung machine.
  • the venous blood flow line 20 receives de-oxygenated blood from the patient, and the arterial blood flow line 30 provides oxygenated blood to the patient. Blood in the blood flow lines 20 and 30 pass through a sterile channel such as tubing.
  • Gas is passed to the oxygenator 40 via a gas module 50 comprising sensors 1 to 3, and gas is passed from the oxygenator 40 to a CO2 module comprising a sensor 4.
  • sensors 1 to 4 are as follows:
  • Sensor 4 Percentage of C0 2 at exit from the oxygenator (C0 2 out) In addition to the above parameters the following are also measured by strategically placed sensors in other locations:
  • Sensor 7 is provided on the blood flow line from the oxygenator 40, sensor 6 is provided on the blood flow line to the oxygenator 40, and sensor 5 is provided in a suitable position for measuring atmospheric pressure.
  • the positions of the sensors 6 and 7 with respect to the oxygenator 40 could be different to that as illustrated.
  • an atmospheric pressure sensor 5 and a line pressure sensor 3 are illustrated, in practice it is possible to employ only one of these. As the gas running through the device is vented to atmosphere the line pressure is almost exactly atmospheric pressure, and since the more accurate of the two would generally be line pressure, in practice it would be the line pressure sensor 3 that is used to determine atmospheric pressure. Therefore, in the description that follows, atmospheric pressure readings are indicated as coming from the line pressure sensor 3, so that a separate atmospheric pressure sensor 5 is not required.
  • Sensors 6 and 7 can be considered as a first group of sensors for directly measuring a corresponding first group of properties of the blood provided to or from the oxygenator 40.
  • Sensors 1 to 4 can be considered as a second group of sensors for directly measuring a corresponding second group of properties of a gas provided to or from the oxygenator 40.
  • a technique been developed according to an embodiment of the present invention that enables arterial P02 and PC02 to be determined (or inferred or predicted or calculated) using readings from the above sensors.
  • Each of sensors 1 to 7 is preferably non-invasive, in that they are not required to contact the blood in order to operate.
  • a typical non-invasive flow rate sensor 6 measures the flow rate of extra-corporeal blood flow in the tubing by employing ultrasonic energy.
  • any sensors which are required solely to enable arterial P02 and PC02 to be determined should be of a non-invasive or non- contact type.
  • an embodiment of the present invention still has the advantage of determining P02 and PC02 levels indirectly; that is, the P02 and PC02 levels are inferred from other measured properties that might anyway be required in the system for other purposes.
  • the range required for the oxygen sensor 1 is thought to be quite wide, and hence a sensor that could deal with 0 to 100% would be preferable.
  • a sensor is available from a company called FIGARO, in the form for example of an oxygen battery type sensor. This sensor also benefits from being temperature compensated.
  • C0 2 sensors 2 and 4 The range required for the C0 2 sensors 2 and 4 is thought to be somewhat lower than that for the oxygen sensor 1 , preferably somewhere in the region of 0 to 5% or 0 to 10%.
  • a sensor is available from a company called Gas Sensing Solutions, in the form of an IR device that provides both analogue and digital outputs from 0 to 20%.
  • an alternative (and perhaps preferred) C0 2 sensor is available from a company called Dynament, in the form of a device having a full scale range of 0 to 10% C0 2 and is temperature compensated: this sensor also uses an infrared measurement technique, with an analogue output, and has proved to be reliable and accurate, with fewer initial reading errors, breakages and zero drift problems compared to other sensors tried.
  • a thermistor arrangement is suitable, for example a 10 K Ohm Negative Temperature Coefficient (NTC) thermistor.
  • NTC Negative Temperature Coefficient
  • Epcos which has a range of 0 to 70 degrees C.
  • a suitable blood flow rate sensor 6 is found in the Spectrum Medical M3 monitor or by Transonic Systems Inc. These provide an accurate measurement of flow over the range of 0 to 10 l/min with a fast response to flow variations.
  • pressure sensors 3 and 5 these could be individual devices as this would provide more accuracy but, as mentioned above, it is likely that they would be one device that would read line pressure only. This works on the principle that the line pressure is very close to atmospheric pressure.
  • These pressure sensors will likely be a strain gauge type however other types of sensors would be perfectly acceptable. A typical sensor range for this measurement would be between 600 and 1300 mBar absolute. Such a sensor is supplied by a company called Sensortechnics.
  • values for P02 and PC02 are derived from measurements from the above-described sensors according to the following functions:
  • P0 2 Function of ⁇ Tblood , Qblood , 0 2 in% , C0 2 in% , C0 2 out% , Pa ⁇ (1 )
  • PC0 2 Function of ⁇ Tblood , Qblood , C0 2 in% , C0 2 out% , Pa ⁇ (2) where:
  • Tblood Blood Temperature (sensor 7; e.g. degrees C)
  • Pa Line or Atmospheric pressure (sensor 3 or 5)
  • the 0 2 measurement should ideally be accurate over a range of pressure and temperature conditions.
  • the chosen sensor is temperature compensated internally further compensation is not required. It has been determined that the following is an appropriate relationship to employ for pressure compensation:
  • Pa Line or Atmospheric pressure (sensor 3 or 5; e.g. mbar)
  • C0 2 in% Function of ⁇ C0 2 in , Pa ⁇ (4)
  • C0 2 out% Function of ⁇ C0 2 out , Pa ⁇ - C0 2 in% (5) where:
  • C0 2 out Raw C0 2 out sensor reading of gas leaving the system (sensor 4; e.g. % concentration)
  • Pa Atmospheric pressure (sensor 3; e.g. mbar)
  • O 2 out% Function of ⁇ 0 2 in% , C0 2 out% ⁇ (6)
  • 0 2 Pa Ca i Line or Atmospheric pressure when 0 2 sensor was calibrated (sensor 3 or 5;
  • C0 2 Pa C ai Line or Atmospheric pressure when C0 2 sensors were calibrated (sensor 3 or 5; e.g. mbar)
  • C0 2 in% C0 2 in * (1 - ((Pa - CO 2 Pa Ca i)/1000))
  • C0 2 out% C0 2 out * (1 - ((Pa - CO 2 Pa C ai)/1000)) - C0 2 in% (9)
  • the system uses a synchronisation point which is where the user provides to the system a set of reading that have been obtained from a Blood Gas Analyser and the system takes a set of predefined readings from sensors. These readings are used by the system to synchronise itself with this point.
  • the readings required from the blood gas analyser are P02 and PC02 measurements, other measurements that are used are taken from the sensors attached to this device. Another way of thinking about this is that synchronisation is a snapshot in time of all sensor readings and results.
  • the P0 2 function uses a number of variables and sensor values to produce a result, including the derived value from function (9) above.
  • the following variables are also available for use:
  • VarQb P02 P0 2 blood flow correction constant (see Appendix 3 or 5)
  • Vartemp 4 Temperature correction constant at O 2 out% of 4 (see Appendix 3 or 5)
  • Vartemp 6 o Temperature correction constant at 0 2 out% of 60 (see Appendix 3 or 5)
  • Tbloodsync Blood Temperature at time of synchronisation (sensor 7; e.g. degrees C)
  • Qbloodsync Blood flow at time of synchronisation (sensor 6; e.g. l/min)
  • P02 sync P0 2 value supplied by the user at time of synchronising (e.g. mmHg)
  • MasterP02 Lut A table of two columns, first column is 0 2 out% and second column is P0 2
  • MasterPO2 60 P02 value from MasterP02 Lut at an 0 2 out% of 60
  • SynctempP02 Lut ((Each P02 value in MasterP02 Lut ) - MasterP02 4 ) * Synctemp ga i n +
  • SyncP02 Lut (Each P02 value in SynctempP02 Lut ) * (P02 sync / (Value from
  • SyncP02 4 P02 value from SyncP02 Lut at an 0 2 out% of 4
  • SyncPO2 60 P02 value from SyncP02 Lut at an 0 2 out% of 60
  • the PC0 2 function uses a number of variables and sensor values to produce a result, including the derived value from function (8) above, and the P0 2 functions above.
  • the following variables are also available for use:
  • MasterPC02 A table of three columns, first column is Qblood second column is
  • TempPC02 A table of two columns, first column is blood temperature difference (between blood temperature at time of synchronisation and run time blood temperature) and second column is PC0 2 temperature corrections value (see Appendix 2 or 4)
  • PC02 s ync PC0 2 value supplied by the user at time of synchronising (e.g.
  • PC02x syn X value from MasterPC02 Lut when Qblood sy nc is input
  • PC02c syn C value from MasterPC02 Uut when Qblood sy nc is input
  • PC02x X value' from MasterPC02 Lu , when Qblood is input
  • PC02c C value from MasterPC02 Lut when Qblood is input
  • PC02 te mp Temperature correction value from TempPC02
  • PC0 2 (((QbC02 * PC02x) + (QbC02 * PC02 temp ) + PC02c) * (MasterPC02 / PC02 sync )
  • a blood analysis method is illustrated schematically in the flow chart of Figure 2.
  • Blood is provided from a patient to the oxygenator 40 in step P1 , and blood is provided from the oxygenator 40 back to the patient in step P2, in a continuous loop.
  • the above-mentioned first group of sensors is provided in step S1
  • the above-mentioned second group of sensors is provided in step S2.
  • Step S3 comprises directly measuring a first group of properties of the blood provided to or from the oxygenator 40 using corresponding respective ones of the first group of sensors.
  • Step S4 comprises directly measuring a second group of properties of a gas provided to or from the oxygenator 40 using corresponding respective ones of the second group of sensors.
  • Step S5 comprises applying corrections to various ones of the measured 011 001602
  • step S6 a value for the partial pressure of oxygen in the blood is determined in dependence upon the first group of directly measured properties (from step S3) and the second group of directly measured properties (from step S4), or a selection thereof.
  • step S7 a value for the partial pressure of carbon dioxide in the blood is determined in dependence upon the first group of directly measured properties (from step S3) and the second group of directly measured properties (from step S4), or a selection thereof.
  • the properties used in steps S6 and S7 may be different. Processing then loops back to step S3, at least until sufficient determinations of P02 and/or PC02 have been made.
  • oxygen and carbon dioxide sensors 1 , 2 and 4 are described as measuring a percentage of oxygen or carbon dioxide (as the case may be), those sensors need not measure actual percentages but may instead provide their measurements in any other suitable unit of concentration, with appropriate adjustments to the functions which use those measurements.
  • first and second processors 60, 70 could be controlled or provided at least in part by a program operating on the device or apparatus.
  • a single processor or processing unit may be arranged to perform the function of both the first and second processors 60, 70.
  • Such an operating program can be stored on a computer-readable medium, or could, for example, be embodied in a signal such as a downloadable data signal provided from an Internet website.
  • the appended claims are to be interpreted as covering an operating program by itself, or as a record on a carrier, or as a signal, or in any other form.
  • the second group of sensors might comprise a single sensor, for measuring a concentration of carbon dioxide in the gas from the oxygenator (40).
  • variables in functions (1 ) and (2) it is also possible to include more variables in functions (1 ) and (2), and the associated more detailed functions derived from these basic functions. For example, one might consider including the current value of PC0 2 in function (1). One might also consider adding further sensors to the first and/or second group of sensors to provide further variables for inclusion in the functions. For example, one might include a further sensor in the first group of sensors for measuring hematocrit / haemoglobin concentration, and include a corresponding variable Hct / Hb in one or both of functions (1 ) and (2). One might include a further sensor in the second group of sensors for measuring gas flow rate, and include a corresponding variable Qgas in one or both of functions (1 ) and (2).
  • Appendices below provide example values for use in the above embodiments. It is possible to use a different set to cater for different scenarios. For example, Appendices 2 and 3 below are considered to be applicable for a "high flow” scenario (a blood flow rate of say 1 to 7 l/min), while Appendices 4 and 5 below are considered to be applicable for a "low flow” scenario (a blood flow rate of say 0 to 3 l/min). Appendix 1 is considered to be applicable for both of these scenarios. Of course, the invention is not limited to use of these particular sets of values, and different values may be devised according to the particular application. 11 001602

Abstract

A blood analysis apparatus is provided for use in a system in which blood from a patient is provided to an oxygenator (40) and in which blood from the oxygenator (40) is provided back to the patient. The apparatus comprises a first group of sensors (6, 7) for directly measuring a corresponding first group of properties of the blood provided to or from the oxygenator (40). The apparatus comprises a second group of sensors (1, 2, 3, 4) for directly measuring a corresponding second group of properties of a gas provided to or from the oxygenator (40). The apparatus comprises a processor (60) for determining a value for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.

Description

Blood Analysis Apparatus and Method
The present invention relates to a blood analysis apparatus and method.
Known blood gas analysers typically provide direct measurements of various properties of the blood, such as pH, partial pressure of oxygen (P02), partial pressure of carbon dioxide (PC02), and oxygen saturation. When relating to arterial blood flow (as opposed to venous blood flow), P02 and PC02 are sometimes known respectively as Pa02 and PaC02, or simply Pa02 and PaC02.
These direct measurements of P02 and PC02 are typically used to evaluate oxygenation of the tissues and pulmonary function. For example, P02 reflects the amount of oxygen gas dissolved in the blood, and is an indicator of the effectiveness of the lungs in transferring oxygen into the blood stream from the air breathed in. Decreased P02 levels may be associated with anaemia, hypoventilation or pulmonary disease. On the other hand, PC02 reflects the exchange of C02 through the lungs to the outside air. Increased levels of PC02 may be caused by pulmonary oedema or lung disease, while decreased levels of PC02 may be caused by hyperventilation or hypoxia.
Known techniques for measuring P02 and PC02 are invasive in the sense that contact is required between the sensor being used and the blood being analysed. Even when the measurements are carried out extra-corporeally, such that some degree of invasiveness is anyway required to extract the blood, contact with blood is undesirable for reasons of hygiene and sensor re-use. Such measurements are also direct in the sense that a sensor is provided whose specific purpose is to measure a value of P02 or PC02, as the case may be; the values are not derived from other measured properties, although other measured properties may be taken into account for reasons of accuracy or adjustment.
The present applicant has appreciated the desirability of providing an apparatus and method for the indirect and/or non-invasive determination of P02 and PC02, for example during cardiopulmonary bypass surgery or when membrane oxygenation of patients blood is carried out, for example extra-corporeal membrane oxygenation (ECMO) procedures.
According to a first aspect of the present invention there is provided a blood analysis apparatus for use in a system in which blood from a patient is provided to an oxygenator and in which blood from the oxygenator is provided back to the patient. A first group of sensors is provided for directly measuring a corresponding first group of properties of the blood provided to or from the oxygenator. A second group of sensors is provided for directly measuring a corresponding second group of properties of a gas provided to or from the oxygenator. A processor is provided for determining a value for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.
According to a second aspect of the present invention there is provided a blood analysis method. Blood is provided from a patient to an oxygenator. Blood is provided from the oxygenator back to the patient. A first group of properties of the blood provided to or from the oxygenator is directly measured using a corresponding first group of sensors. A second group of properties of a gas provided to or from the oxygenator is directly measured using a corresponding second group of sensors. A value is determined for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.
At least one of the first group of sensors may be adapted to measure its corresponding property without coming into contact with the blood. It may be that each of the first group of sensors is adapted to measure its corresponding property without coming into contact with the blood.
The first group of sensors may comprise a blood temperature sensor for measuring a temperature of the blood provided to or from the oxygenator and a blood flow rate sensor for measuring a flow rate of the blood provided to or from the oxygenator. The second group of sensors may comprise a carbon dioxide out sensor for measuring a concentration of carbon dioxide in the gas provided from the oxygenator.
The partial pressure of carbon dioxide in the blood may be determined in dependence upon the measurements of blood temperature, blood flow rate, and concentration of carbon dioxide in the gas provided from the oxygenator.
The second group of sensors may comprise an oxygen in sensor for measuring a concentration of oxygen in the gas provided to the oxygenator. The partial pressure of oxygen in the blood may be determined in dependence upon the measurements of blood temperature, blood flow rate, concentration of carbon dioxide in the gas provided from the oxygenator, and concentration of oxygen in the gas provided to the oxygenator.
The second group of sensors may comprise a carbon dioxide in sensor for measuring a concentration of carbon dioxide in the gas provided to the oxygenator. The partial pressure may be determined in dependence upon the measurement of concentration of carbon dioxide in the gas provided to the oxygenator.
The first group of sensors may comprise one or both of a haemoglobin sensor for measuring a level of haemoglobin in the blood provided to or from the oxygenator and a blood saturation sensor for measuring a level of red blood cell oxygen saturation provided to or from the oxygenator. The partial pressure may be determined in dependence upon the measurement of haemoglobin and/or blood saturation level.
The second group of sensors may comprise one or both of a gas temperature sensor for measuring a temperature of the gas provided to or from the oxygenator and a gas flow rate sensor for measuring a gas flow rate of the gas provided to or from the oxygenator. The partial pressure may be determined in dependence upon the measurement of gas temperature and/or flow rate.
The blood analysis apparatus may comprise a pressure sensor for measuring atmospheric pressure. The blood analysis method may comprise measuring atmospheric pressure. The partial pressure may be determined in dependence upon the measurement of atmospheric pressure.
The pressure sensor may form part of the second group of sensors.
The blood analysis apparatus may comprise a second processor for applying a correction to one or more of the measurements of concentration. The blood analysis method may comprise applying a correction to one or more of the measurements of concentration.
The partial pressure of oxygen in the blood may be determined according to function (11 ) below. The partial pressure of carbon dioxide in the blood may be determined according to function (12) below.
Each of the sensors is adapted to measure its corresponding respective property extracorporeal^. Therefore, a method and apparatus according to an embodiment of the present invention is intended to be used extra-corporeally, and not directly on the human or animal body.
According to a third aspect of the present invention there is provided a program for controlling an apparatus to perform a method according to the second aspect of the present invention or which, when loaded into an apparatus, causes the apparatus to become an apparatus according to the first aspect of the present invention. The program may be carried on a carrier medium. The carrier medium may be a storage medium. The carrier medium may be a transmission medium.
According to an fourth aspect of the present invention there is provided an apparatus programmed by a program according to the third aspect of the present invention.
According to a fifth aspect of the present invention there is provided a storage medium containing a program according to the third aspect of the present invention.
Reference will now be made, by way of example, to the accompanying drawings, in which:
Figure 1 illustrates a system embodying the present invention; and
Figure 2 illustrates a method embodying the present invention.
As mentioned above, the aim of an embodiment of the present invention is to determine the levels of P02 and PC02 within the arterial blood stream, and in particular to achieve this by indirect and/or non-invasive means.
The present applicant has appreciated that, in a situation where cardiopulmonary bypass surgery is being undertaken or when membrane oxygenation of patients blood (e.g. ECMO) is being carried out, there is a possibility of determining P02 and PC02 levels by monitoring the gas conditions being presented to the oxygenator and the gas conditions leaving the oxygenator.
There are several equations that are used in everyday medicine which provide a certain amount of knowledge about the relationship between the gas breathed in and out and the amount of P02 and PC02 that occurs in the blood stream.
A first equation of interest is the following for arterial oxygen content (Ca02):
CaQ2 = Hb(gm/dl)\ 34(02 /gm)Hb *Sa02 +Pa02 * 0.003(m/O2 ImmHgldl)
However, the present applicant has appreciated that the measurements of Sa02 (arterial oxygen saturation) and Hb (haemoglobin) are needed at a very high precision for this equation to be effective. Furthermore, Pa02 is required, which is what an embodiment of the present invention is seeking to determine.
The well-known alveolar gas equation is also of interest (where PA02 is alveolar P02 rather than arterial P02 or Pa02):
PA02 = FI02 {BP - 47) - 12PaC02
In the above equation, FI02 is the fraction of inspired oxygen.
The properties that one might therefore consider to be relevant to the above are:
Oxygen % in
Atmospheric pressure
Carbon Dioxide % out
However, the present applicant has appreciated that, although the above equations are physiologically correct, they cannot be used to determine P02 or PC02 when an oxygenator is involved. The oxygenator efficiency and performance has been found to override the equations to make the accuracy unacceptable. However, some of the basic principles can be used in an embodiment of the present invention. The present applicant has therefore appreciated the importance of taking account of and characterising the oxygenator system, and having functions that allow a basic equation to be used and to allow each function to modify the result by correcting for changes in various variables.
The variables (or properties) that have been identified as being useful are, but are not limited to:
Oxygen % in
Carbon Dioxide % in
Blood Temperature
Blood flow rate
Carbon Dioxide % out
Figure 1 illustrates a system embodying the present invention. With a system embodying the present invention, extra-corporeal blood property measurements are made externally of the patient, typically during a procedure in which the patient's blood is routed through a system such as a heart lung machine during a heart bypass operation.
The system comprises a venous blood flow line 20, an arterial blood flow line 30 and an oxygenator 40, for example as part of a heart-lung machine. Thus, in the illustrated example, the venous blood flow line 20 receives de-oxygenated blood from the patient, and the arterial blood flow line 30 provides oxygenated blood to the patient. Blood in the blood flow lines 20 and 30 pass through a sterile channel such as tubing.
Gas is passed to the oxygenator 40 via a gas module 50 comprising sensors 1 to 3, and gas is passed from the oxygenator 40 to a CO2 module comprising a sensor 4. These sensors 1 to 4 are as follows:
Sensor 1 : Percentage of oxygen at inlet to the oxygenator (02)
Sensor 2: Percentage of CO2 at inlet to the oxygenator (C02in)
Sensor 3: Gas line pressure
Sensor 4: Percentage of C02 at exit from the oxygenator (C02out) In addition to the above parameters the following are also measured by strategically placed sensors in other locations:
Sensor 5: atmospheric pressure
Sensor 6: blood flow rate
Sensor 7: blood temperature
Sensor 7 is provided on the blood flow line from the oxygenator 40, sensor 6 is provided on the blood flow line to the oxygenator 40, and sensor 5 is provided in a suitable position for measuring atmospheric pressure. The positions of the sensors 6 and 7 with respect to the oxygenator 40 could be different to that as illustrated.
Although an atmospheric pressure sensor 5 and a line pressure sensor 3 are illustrated, in practice it is possible to employ only one of these. As the gas running through the device is vented to atmosphere the line pressure is almost exactly atmospheric pressure, and since the more accurate of the two would generally be line pressure, in practice it would be the line pressure sensor 3 that is used to determine atmospheric pressure. Therefore, in the description that follows, atmospheric pressure readings are indicated as coming from the line pressure sensor 3, so that a separate atmospheric pressure sensor 5 is not required.
Sensors 6 and 7 can be considered as a first group of sensors for directly measuring a corresponding first group of properties of the blood provided to or from the oxygenator 40.
Sensors 1 to 4 can be considered as a second group of sensors for directly measuring a corresponding second group of properties of a gas provided to or from the oxygenator 40.
A more detailed description of each of the sensors 1 to 7 is provided below.
A technique been developed according to an embodiment of the present invention that enables arterial P02 and PC02 to be determined (or inferred or predicted or calculated) using readings from the above sensors. Each of sensors 1 to 7 is preferably non-invasive, in that they are not required to contact the blood in order to operate. For example, a typical non-invasive flow rate sensor 6 measures the flow rate of extra-corporeal blood flow in the tubing by employing ultrasonic energy. In order to achieve the aim of being able to determine arterial P02 and PC02 non-invasively, any sensors which are required solely to enable arterial P02 and PC02 to be determined should be of a non-invasive or non- contact type. However, even if an invasive type sensor is used, an embodiment of the present invention still has the advantage of determining P02 and PC02 levels indirectly; that is, the P02 and PC02 levels are inferred from other measured properties that might anyway be required in the system for other purposes.
It is preferable that levels of arterial P02 and PC02 are corrected for the following interfering variables:
Temperature variations
Pressure variations
Blood flow rate variations
Oxygen inlet percentage variations
Carbon dioxide inlet and outlet variations
To provide the system with these corrections, various sensors can be used as detailed in the above list.
The range required for the oxygen sensor 1 is thought to be quite wide, and hence a sensor that could deal with 0 to 100% would be preferable. Such a sensor is available from a company called FIGARO, in the form for example of an oxygen battery type sensor. This sensor also benefits from being temperature compensated.
The range required for the C02 sensors 2 and 4 is thought to be somewhat lower than that for the oxygen sensor 1 , preferably somewhere in the region of 0 to 5% or 0 to 10%. Such a sensor is available from a company called Gas Sensing Solutions, in the form of an IR device that provides both analogue and digital outputs from 0 to 20%. However, an alternative (and perhaps preferred) C02 sensor is available from a company called Dynament, in the form of a device having a full scale range of 0 to 10% C02 and is temperature compensated: this sensor also uses an infrared measurement technique, with an analogue output, and has proved to be reliable and accurate, with fewer initial reading errors, breakages and zero drift problems compared to other sensors tried.
For the temperature sensor 7, a thermistor arrangement is suitable, for example a 10 K Ohm Negative Temperature Coefficient (NTC) thermistor. Such a sensor is supplied by a company called Epcos which has a range of 0 to 70 degrees C.
A suitable blood flow rate sensor 6 is found in the Spectrum Medical M3 monitor or by Transonic Systems Inc. These provide an accurate measurement of flow over the range of 0 to 10 l/min with a fast response to flow variations.
For pressure sensors 3 and 5 these could be individual devices as this would provide more accuracy but, as mentioned above, it is likely that they would be one device that would read line pressure only. This works on the principle that the line pressure is very close to atmospheric pressure. These pressure sensors will likely be a strain gauge type however other types of sensors would be perfectly acceptable. A typical sensor range for this measurement would be between 600 and 1300 mBar absolute. Such a sensor is supplied by a company called Sensortechnics.
In an embodiment of the present invention, values for P02 and PC02 are derived from measurements from the above-described sensors according to the following functions:
P02 = Function of {Tblood , Qblood , 02in% , C02in% , C02out% , Pa} (1 ) PC02 = Function of {Tblood , Qblood , C02in% , C02out% , Pa} (2) where:
Tblood = Blood Temperature (sensor 7; e.g. degrees C)
Qblood = Blood Flow Rate (sensor 6)
02in% = 02 percentage entering system (various sensors; see below)
C02in% = C02 percentage entering system (various sensors; see below)
C02out% = C02 percentage in gas leaving system removed from blood (various
sensors; see below)
Pa = Line or Atmospheric pressure (sensor 3 or 5)
The values for P02 and PC02 given respectively by functions (1) and (2) are calculated by the first processor (60) illustrated in Figure 1 , in dependence upon readings or a subset of readings from the first group of sensors, the second group of sensors, and any other sensors provided. 11 001602
10
The above-mentioned values for 02in%, C02in% and C02out% are derived from sensor readings which benefit from correction in order to improve performance and accuracy.
In this respect, the 02 measurement should ideally be accurate over a range of pressure and temperature conditions. As the chosen sensor is temperature compensated internally further compensation is not required. It has been determined that the following is an appropriate relationship to employ for pressure compensation:
02in% = Function of {02 , Pa} (3) where:
Pa = Line or Atmospheric pressure (sensor 3 or 5; e.g. mbar)
02 = Raw 02 sensor reading (sensor 1; e.g. % concentration)
There are two C02 measurements of interest, one being the gas entering the system and the other being the difference between the gas entering and the gas leaving. These measurements should also ideally be accurate over a range of a pressure and temperature conditions. As the chosen sensor is temperature compensated internally further compensation is not required. It has been determined that the following is an appropriate relationship to employ for pressure compensation:
C02in% = Function of {C02in , Pa} (4) C02out% = Function of {C02out , Pa} - C02in% (5) where:
C02in = Raw C02in sensor reading of gas entering the system (sensor 2; e.g. % concentration)
C02out = Raw C02out sensor reading of gas leaving the system (sensor 4; e.g. % concentration)
Pa = Atmospheric pressure (sensor 3; e.g. mbar)
As the gas passes through the oxygenator 40, oxygen is absorbed by the blood and carbon dioxide is released. As a result of this, the gas exchange mix that is present as it B2011/001602
11 finishes passing over the blood is not the same as the gas concentration that entered the oxygenator chamber. This final, condition of the gas can be approximated by subtracting the amount of C02 exiting from the 02 entering. It has been determined that the following is an appropriate relationship to employ for providing this corrected reading:
O2out% = Function of {02in% , C02out%} (6)
The corrected values for 02in%, 02out%, C02in% and C02out% given respectively by functions (3) to (6) are calculated by the second processor (70) illustrated in Figure 1.
Each of the basic functions set out in (1 ) to (6) above can now be described in more detail, so that the specific interactions of each of the above variables can be shown.
Turning first to function (3), and as mentioned above, in order to ensure that the measured 02in% is correct over a range of known use conditions it should ideally be corrected for pressure. In order to do this, the following variables are used to act upon the pressure measurements which are then used to calculate 02in%:
02PaCai = Line or Atmospheric pressure when 02 sensor was calibrated (sensor 3 or 5;
e.g. mbar)
And, based on the above, the function (3) for 02in% becomes:
02in% = 02 * (1 - ((Pa - 02PaCai)/1000)) (7)
Turning now to functions (4) and (5), and as mentioned above, in order to ensure that the measured C02in% and C02out% values are correct over a range of known use conditions they should ideally be corrected for pressure. In order to do this, the following variables are used to act upon the pressure measurements which are then used to calculate C02in% and C02out%:
C02PaCai = Line or Atmospheric pressure when C02 sensors were calibrated (sensor 3 or 5; e.g. mbar)
And, based on the above, the functions (4) and (5) for C02in% and C02out% become: C02in% = C02in * (1 - ((Pa - CO2PaCai)/1000)) (8) C02out% = C02out * (1 - ((Pa - CO2PaCai)/1000)) - C02in% (9)
Turning now to function (6), as mentioned above, in order to provide a corrected reading for 02in% which can be used for the final condition of the gas mix within the oxygenator the following variable are used to create 02out%:
02out% = (02in% - C02out%) (10)
The system uses a synchronisation point which is where the user provides to the system a set of reading that have been obtained from a Blood Gas Analyser and the system takes a set of predefined readings from sensors. These readings are used by the system to synchronise itself with this point. The readings required from the blood gas analyser are P02 and PC02 measurements, other measurements that are used are taken from the sensors attached to this device. Another way of thinking about this is that synchronisation is a snapshot in time of all sensor readings and results.
Turning now to function (1 ), the P02 function uses a number of variables and sensor values to produce a result, including the derived value from function (9) above. For a more accurate result, the following variables are also available for use:
VarQbP02 = P02 blood flow correction constant (see Appendix 3 or 5)
Vartemp4 = Temperature correction constant at O2out% of 4 (see Appendix 3 or 5)
Vartemp6o = Temperature correction constant at 02out% of 60 (see Appendix 3 or 5)
Tbloodsync = Blood Temperature at time of synchronisation (sensor 7; e.g. degrees C)
Qbloodsync = Blood flow at time of synchronisation (sensor 6; e.g. l/min)
02out%sync = 02out% at time of synchronisation (function 10)
P02sync = P02 value supplied by the user at time of synchronising (e.g. mmHg)
MasterP02Lut = A table of two columns, first column is 02out% and second column is P02
Values (see Appendix 1 )
These are used to derive the following:
QbP02 = (Qblood - Qbloodsync) * VarQbP02 MasterP024 = P02 value from asterP02Lut at an O2out% of 4
MasterPO260 = P02 value from MasterP02Lut at an 02out% of 60
Synctempgain = ((Vartempeo* (Tbloodsync- 37) * MasterPO260 + MasterPO260) - (Vartemp4
* (Tbloodsync - 37) + asterP024)) / (MasterPO260 - MasterP024)
SynctempP02Lut= ((Each P02 value in MasterP02Lut) - MasterP024) * Synctempgain +
(Vartemp4 * (Tbloodsync- 37) + MasterP024)
SyncP02Lut= (Each P02 value in SynctempP02Lut) * (P02sync / (Value from
SynctempP02Lut when O2out%sync is input))
SyncP024 = P02 value from SyncP02Lut at an 02out% of 4
SyncPO260 = P02 value from SyncP02Lut at an 02out% of 60
Workinggain = ((Vartemp60 * (Tblood - Tbloodsync) * SyncPO260 + SyncPO260) - (Vartemp4
* (Tblood - Tbioodsync) + SyncP024)) / (SyncPO260 - SyncP024)
And from this the following can be derived:
= (((Each P02 value in SyncP02LLrt) - SyncP024) * Workinggain +
(Vartemp4 * (Tblood - Tbloodsync) + SyncP024)) - ((Qblood - Qblood, VarQbpo2)
Value from Working P02Lut when 02out% is input (11)
Turning now to function (2), the PC02 function uses a number of variables and sensor values to produce a result, including the derived value from function (8) above, and the P02 functions above. For a more accurate result, the following variables are also available for use:
C02out% = C02out% (function 9) at time of synchronisation
MasterPC02, = A table of three columns, first column is Qblood second column is
X values and third column is C values (see Appendix 2 or 4)
TempPC02, = A table of two columns, first column is blood temperature difference (between blood temperature at time of synchronisation and run time blood temperature) and second column is PC02 temperature corrections value (see Appendix 2 or 4)
Note : X and C values referred to above are gain and offsets for the generation of a straight line.(e.g. Y=mX+C) in this case m = Qblood, so for each Qblood entry in the table a bespoke straight line can be generated.
PC02sync = PC02 value supplied by the user at time of synchronising (e.g.
mmHg)
PC02xsyn = X value from MasterPC02Lut when Qbloodsync is input
PC02csyn = C value from MasterPC02Uut when Qbloodsync is input
PC02x = X value' from MasterPC02Lu, when Qblood is input
PC02c = C value from MasterPC02Lut when Qblood is input
PC02temp = Temperature correction value from TempPC02|Ut when (Tbood - Tbloodsync) is input
MasterPC02 = ((Qbloodsync * C02out%sync) * PC02xsync) + PC02csync
QbC02 = Qblood * C02out%
And from this the following can be derived:
PC02 = (((QbC02 * PC02x) + (QbC02 * PC02temp) + PC02c) * (MasterPC02 / PC02sync)
(12)
A blood analysis method according to an embodiment of the present invention is illustrated schematically in the flow chart of Figure 2. Blood is provided from a patient to the oxygenator 40 in step P1 , and blood is provided from the oxygenator 40 back to the patient in step P2, in a continuous loop. The above-mentioned first group of sensors is provided in step S1, while the above-mentioned second group of sensors is provided in step S2. Step S3 comprises directly measuring a first group of properties of the blood provided to or from the oxygenator 40 using corresponding respective ones of the first group of sensors. Step S4 comprises directly measuring a second group of properties of a gas provided to or from the oxygenator 40 using corresponding respective ones of the second group of sensors. Step S5 comprises applying corrections to various ones of the measured 011 001602
15 properties, for example as set out above with reference to functions (6) to (10). In step S6 a value for the partial pressure of oxygen in the blood is determined in dependence upon the first group of directly measured properties (from step S3) and the second group of directly measured properties (from step S4), or a selection thereof. In step S7 a value for the partial pressure of carbon dioxide in the blood is determined in dependence upon the first group of directly measured properties (from step S3) and the second group of directly measured properties (from step S4), or a selection thereof. The properties used in steps S6 and S7 may be different. Processing then loops back to step S3, at least until sufficient determinations of P02 and/or PC02 have been made.
It will be appreciated that, for any sensors illustrated in Figure 1 but not included in any function described above, those sensors may be useful for further enhancements to an embodiment of the present invention, for example in order to provide a more accurate determination of P02 and PC02. It will also be understood that the specific calculations described above with reference to functions (1) to (12) are intended to be illustrative and not limiting; it is perfectly feasible to apply different specific calculations in other embodiments of the present invention.
It will be understood that although the oxygen and carbon dioxide sensors 1 , 2 and 4 are described as measuring a percentage of oxygen or carbon dioxide (as the case may be), those sensors need not measure actual percentages but may instead provide their measurements in any other suitable unit of concentration, with appropriate adjustments to the functions which use those measurements.
It will be appreciated that operation of one or both of the first and second processors 60, 70 could be controlled or provided at least in part by a program operating on the device or apparatus. A single processor or processing unit may be arranged to perform the function of both the first and second processors 60, 70. Such an operating program can be stored on a computer-readable medium, or could, for example, be embodied in a signal such as a downloadable data signal provided from an Internet website. The appended claims are to be interpreted as covering an operating program by itself, or as a record on a carrier, or as a signal, or in any other form.
It will be understood that not all of the variables included in the above-described functions, and in particular in the basic functions (1 ) and (2), are essential. Generally, the more B2011/001602
16 variables that are used in the function, the more accurate the resulting derivation of P02 and PC02, but it is possible to sacrifice a little accuracy by dropping those variables that contribute less to the overall accuracy. This would in turn reduce the overall complexity of the calculations, and also the overall number of sensors required. For example, it might also be possible to drop C02in% from function (1 ). Depending on the types of sensors employed, and whether correction for pressure is required, it may also be possible to drop Pa from functions (1) and (2). What variables are included will depend on the particular application, and the accuracy required.
Therefore, the following cut-down version of functions (1) and (2) might be considered:
P02 = Function of {Tblood , Qblood , 02in% , C02out%} (1 ') PC02 = Function of {Tblood , Qblood , C02out%} (2')
Therefore, at least in respect of function (2') above, the second group of sensors might comprise a single sensor, for measuring a concentration of carbon dioxide in the gas from the oxygenator (40).
A similar situation applies to the correction functions (3) to (6); certain variables could be left out, depending on the accuracy required. For example, C02in% could be dropped from function (5). Again, what variables are included will depend on the particular application.
Likewise, it is also possible to include more variables in functions (1 ) and (2), and the associated more detailed functions derived from these basic functions. For example, one might consider including the current value of PC02 in function (1). One might also consider adding further sensors to the first and/or second group of sensors to provide further variables for inclusion in the functions. For example, one might include a further sensor in the first group of sensors for measuring hematocrit / haemoglobin concentration, and include a corresponding variable Hct / Hb in one or both of functions (1 ) and (2). One might include a further sensor in the second group of sensors for measuring gas flow rate, and include a corresponding variable Qgas in one or both of functions (1 ) and (2). One might include a further sensor in the second group of sensors for measuring gas temperature, and include a corresponding variable Tgas in one or more of functions (3) to (5). One might include a further sensor in the first group of sensors for measuring blood saturation, and include a corresponding variable Sa02% in one or more of the functions.
It will also be appreciated by the person of skill in the art that various modifications may be made to the above-described embodiments without departing from the scope of the present invention as defined by the appended claims.
During cardiopulmonary bypass surgery the patient body temperature is often lowered during the procedure. The measurements already described above (equations 11 and 12) provide values of p02 and pC02 at a reference temperature of 37 degrees C, which is a typical measurement from a blood gas analyser. However if p02 and pC02 measurements are required at the temperature the sample is taken then additional calculations can be performed to provide these new values:
Figure imgf000018_0001
PC02@Te p = pcO2 *l00m9*{m°od' 1) (14)
Appendices
The appendices below provide example values for use in the above embodiments. It is possible to use a different set to cater for different scenarios. For example, Appendices 2 and 3 below are considered to be applicable for a "high flow" scenario (a blood flow rate of say 1 to 7 l/min), while Appendices 4 and 5 below are considered to be applicable for a "low flow" scenario (a blood flow rate of say 0 to 3 l/min). Appendix 1 is considered to be applicable for both of these scenarios. Of course, the invention is not limited to use of these particular sets of values, and different values may be devised according to the particular application. 11 001602
18
Appendix 1
Example of MasterP02Uut Look Up Table:
02out P02
% mmhg
4.000 41.500
6.000 44.400
8.000 48.300
10.000 51.200
12.000 56.000
14.000 60.000
16.000 64.700
18.000 70.500
20.000 76.300
22.000 81.780
24.000 88.800
26.000 96.600
28.000 105.300
30.000 115.900
32.000 126.300
34.000 137.200
36.000 148.800
38.000 161.400
40.000 174.700
42.000 188.500
44.000 203.300
46.000 217.400
48.000 234.800
50.000 252.200
52.000 270.500
54.000 287.900
56.000 302.400
58.000 317.900 60.000 334.300
62.000 347.800
64.000 359.400
66.000 371.000
68.000 382.600
70.000 396.100
72.000 406.800
74.000 419.300
76.000 427.100
78.000 435.700
80.000 443.500
Appendix 2
(A) Example of MasterPC02Lut Look up Table: for High flow assembly (1 to 7 l/min)
Absolute
Blood
flow
Qblood X C
l/min
0.5 20.4 2
1 18 2
1.5 16 2
2 14.1 2
3 10.89 2
4 8.5 2
5 7.6 2
6 7.3 2
7 7.2 2
(B) Example of TempPC02lut Look up Table: for High flow assembly (1 to 7 l/min) Blood
Temp Diff PC02 temperature correction
Deg C
-22.00 19.00
-17.00 14.00
-12.00 9.50
-7.00 5.00
0.00 0.00
7.00 -3.00
12.00 -6.00
17.00 -8.20
22.00 -11.00 Appendix 3 Examples of Constants used: for High flow assembly (1 to 7 l/min)
VarQbpoz = 12
Vartemp4 = -3.852
Vartempeo = -0.040
Appendix 4
(A) Example of MasterPC02Lut Look up Table: for Low flow assembly (0 to 3 l/min)
Absolute
Blood
flow
Qblood X C
l/min
0.5 24.41 2
1 16.54 2
1.5 11.4 2
2 8.6 2
2.5 6.89 2
3 5.76 2
(B) Example of TempPC02|Ut Look up Table: for Low flow assembly (0 to 3 l/min) Blood
Temp Diff PC02 temperature correction
Deg C
-22.00 23.6
-17.00 17.70
-12.00 1 1.80
-7.00 6.70
0.00 0.00
7.00 -3.00
12.00 -6.00
17.00 -8.20
22.00 -1 1.00 Appendix 5
Examples of Constants used: for Low flow assembly (0 to 3 l/min) VarQbp02 = 30
Vartemp4 = -3.852
Vartempeo = -0.022

Claims

Claims
1 . A blood analysis apparatus for use in a system in which blood from a patient is provided to an oxygenator (40) and in which blood from the oxygenator (40) is provided back to the patient, the apparatus comprising a first group of sensors for directly measuring a corresponding first group of properties of the blood provided to or from the oxygenator (40), a second group of sensors for directly measuring a corresponding second group of properties of a gas provided to or from the oxygenator (40), and a processor (60) for determining a value for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.
2. A blood analysis method comprising: providing blood from a patient to an oxygenator (40); providing blood from the oxygenator (40) back to the patient; directly measuring a first group of properties of the blood provided to or from the oxygenator (40) using a corresponding first group of sensors; directly measuring a second group of properties of a gas provided to or from the oxygenator (40) using a corresponding second group of sensors; and determining a value for the partial pressure of oxygen in the blood and/or a value for the partial pressure of carbon dioxide in the blood in dependence upon the first group of directly measured properties and the second group of directly measured properties.
3. A blood analysis apparatus or method as claimed in claim 1 or 2, wherein at least one of the first group of sensors is adapted to measure its corresponding property without coming into contact with the blood.
4. A blood analysis apparatus or method as claimed in claim 3, wherein each of the first group of sensors is adapted to measure its corresponding property without coming into contact, with the blood.
5. A b!ood analysis apparatus or method as claimed in any preceding claim, wherein the first group of sensors comprises a blood temperature sensor (7) for measuring a temperature of the blood provided to or from the oxygenator (40) and a blood flow rate sensor (6) for measuring a flow rate of the blood provided to or from the oxygenator (40), and wherein the second group of sensors comprises a carbon dioxide out sensor (4) for measuring a concentration of carbon dioxide in the gas provided from the oxygenator (40).
6. A blood analysis apparatus or method as claimed in claim 5, wherein the partial pressure of carbon dioxide in the blood is determined in dependence upon the measurements of blood temperature, blood flow rate, and concentration of carbon dioxide in the gas provided from the oxygenator.
7. A blood analysis apparatus or method as claimed in claim 5 or 6, wherein the second group of sensors comprises an oxygen in sensor (1 ) for measuring a concentration of oxygen in the gas provided to the oxygenator (40), and wherein the partial pressure of oxygen in the blood is determined in dependence upon the measurements of blood temperature, blood flow rate, concentration of carbon dioxide in the gas provided from the oxygenator (40), and concentration of oxygen in the gas provided to the oxygenator (40).
8. A blood analysis apparatus or method as claimed in claim 5, 6 or 7, wherein the second group of sensors comprises a carbon dioxide in sensor (2) for measuring a concentration of carbon dioxide in the gas provided to the oxygenator (40), and wherein the partial pressure is determined in dependence upon the measurement of concentration of carbon dioxide in the gas provided to the oxygenator (40).
9. A blood analysis apparatus or method as claimed in any one of claims 5 to 8, wherein the first group of sensors comprises one or both of a haemoglobin sensor for measuring a level of haemoglobin in the blood provided to or from the oxygenator (40) and a blood saturation sensor for measuring a level of blood saturation in the blood provided to or from the oxygenator (40), and wherein the partial pressure is determined in dependence upon the measurement of haemoglobin and/or blood saturation level.
10. A blood analysis apparatus or method as claimed in any one of claims 5 to 9, wherein the second group of sensors comprises one or both of a gas temperature sensor for measuring a temperature of the gas provided to or from the oxygenator (40) and a gas flow rate sensor for measuring a gas flow rate of the gas provided to or from the oxygenator (40), and wherein the partial pressure is determined in dependence upon the measurement of gas temperature and/or flow rate.
1 . A blood analysis apparatus or method as claimed in any one of claims 5 to 10, comprising a pressure sensor (3; 5) for measuring atmospheric pressure, and wherein the partial pressure is determined in dependence upon the measurement of atmospheric pressure.
12. A blood analysis apparatus or method as claimed in claim 1 1 , wherein the pressure sensor (3) forms part of the second group of sensors.
13. A blood analysis apparatus or method as claimed in any one of claims 5 to 12, comprising a second processor for applying a correction to one or more of the measurements of concentration.
1 . A blood analysis apparatus or method as claimed in any preceding claim, wherein the partial pressure of oxygen in the blood is determined according to function (11 ) in the appended description.
15. A blood analysis apparatus or method as claimed in any preceding claim, wherein the partial pressure of carbon dioxide in the blood is determined according to function (12) in the appended description.
16. A program for controlling an apparatus to perform a method as claimed in any one of claims 2 to 15, optionally being carried on a carrier medium such as a storage medium or a transmission medium.
17. A storage medium containing a program as claimed in claim 16.
PCT/GB2011/001602 2010-11-18 2011-11-15 Blood analysis apparatus and method WO2012066280A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1019488.4A GB2485558B (en) 2010-11-18 2010-11-18 Blood analysis apparatus for use with an oxygenator
GB1019488.4 2010-11-18

Publications (2)

Publication Number Publication Date
WO2012066280A2 true WO2012066280A2 (en) 2012-05-24
WO2012066280A3 WO2012066280A3 (en) 2012-08-02

Family

ID=43431606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2011/001602 WO2012066280A2 (en) 2010-11-18 2011-11-15 Blood analysis apparatus and method

Country Status (2)

Country Link
GB (1) GB2485558B (en)
WO (1) WO2012066280A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2540724A (en) * 2015-03-06 2017-02-01 Spectrum Medical Ltd Blood analysis apparatus and method
CN109498936A (en) * 2018-10-15 2019-03-22 北京工业大学 A kind of oxygen supply decision system that extracorporeal life is supported
CN109745591A (en) * 2019-02-01 2019-05-14 江苏赛腾医疗科技有限公司 A kind of Ambulatory monitoring host and cardiopulmonary bypass system
CN112153993A (en) * 2018-05-24 2020-12-29 欧赛特有限公司 Device for measuring carbon dioxide removed by oxygenator

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX364090B (en) * 2013-06-13 2019-04-12 Koninklijke Philips Nv Device and method for determining a partial carbon dioxide pressure in a subject of interest.
GB2533027B (en) 2014-12-03 2020-06-03 Spectrum Medical Ltd Control system
GB2557863B (en) * 2014-12-03 2020-09-16 Spectrum Medical Ltd Ventilation System

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591399A (en) * 1993-10-14 1997-01-07 Goldman; Julian M. System for diagnosing oxygenator failure
US5770149A (en) * 1995-10-31 1998-06-23 Baxter International Extracorporeal blood oxygenation system having integrated blood pump, heat exchanger and membrane oxygenator
NO20041611D0 (en) * 2004-04-20 2004-04-20 Rikshospitalet Universitetskli Method and apparatus for estimating a PaCO2 value for a patient having extracorporeal blood circulation
WO2007075089A1 (en) * 2005-12-29 2007-07-05 Rikshospitalet-Radiumhospitalet Hf Method and apparatus for estimating a pao2 value for a patient subject to extracorporeal circulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2540724A (en) * 2015-03-06 2017-02-01 Spectrum Medical Ltd Blood analysis apparatus and method
US10835661B2 (en) 2015-03-06 2020-11-17 Spectrum Medical Ltd. Blood analysis apparatus and method
CN112153993A (en) * 2018-05-24 2020-12-29 欧赛特有限公司 Device for measuring carbon dioxide removed by oxygenator
CN109498936A (en) * 2018-10-15 2019-03-22 北京工业大学 A kind of oxygen supply decision system that extracorporeal life is supported
CN109745591A (en) * 2019-02-01 2019-05-14 江苏赛腾医疗科技有限公司 A kind of Ambulatory monitoring host and cardiopulmonary bypass system
WO2020155237A1 (en) * 2019-02-01 2020-08-06 江苏赛腾医疗科技有限公司 Portable monitoring apparatus and cardiopulmonary bypass system

Also Published As

Publication number Publication date
GB201019488D0 (en) 2010-12-29
WO2012066280A3 (en) 2012-08-02
GB2485558B (en) 2018-04-25
GB2485558A (en) 2012-05-23

Similar Documents

Publication Publication Date Title
WO2012066280A2 (en) Blood analysis apparatus and method
Johnson Jr et al. Pulmonary capillary blood volume, flow and diffusing capacity during exercise
EP1372480B1 (en) Rebreathing system including oscillating rebreathing and non-rebreathing periods
US10556052B2 (en) Control system
US7766857B2 (en) Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration
US20130109978A1 (en) Non-invasive cardiac output determination
US10835661B2 (en) Blood analysis apparatus and method
CN106659436B (en) Arterial CO2Measurement of partial pressure
EP2552312B1 (en) Determining components of total carbon dioxide excreted by a subject
US20200345269A1 (en) Method and system for estimating the efficiency of the lungs of a patient
Allingstrup et al. Indirect calorimetry in mechanically ventilated patients: a prospective, randomized, clinical validation of 2 devices against a gold standard
Williams et al. Within‐breath arterial P o2 oscillations in an experimental model of acute respiratory distress syndrome
EP2819572A1 (en) Method for calibrating the level of oxygen in respiratory gas related to the level of oxygen in the blood circulation of an individual
EP3451923B1 (en) Capnotracking of cardiac output or effective pulmonary blood floow during mechanical ventilation
CA2997405A1 (en) Determination of gases dissolved in blood in the extracorporeal circulation
Trulock III Arterial blood gases
Berger et al. Integral assessment of gas exchange during veno-arterial ECMO: accuracy and precision of a modified Fick principle in a porcine model
Potger et al. Membrane oxygenator exhaust capnography for continuously estimating arterial carbon dioxide tension during cardiopulmonary bypass
EP3082594B1 (en) Method and apparatus for estimating shunt
Kristiansen et al. Clinical evaluation of an instrument to measure carbon dioxide tension at the oxygenator gas outlet in cardiopulmonary bypass
Baraka et al. Oxygenator exhaust capnography for prediction of arterial carbon dioxide tension during hypothermic cardiopulmonary bypass
Berger et al. Translational Physiology: Integral assessment of gas exchange during veno-arterial ECMO: accuracy and precision of a modified Fick principle in a porcine model
SIGGAARD‐ANDERSEN et al. Oxygen parameters of arterial and mixed venous blood,‐new and old
Bellaiche et al. Clinical evaluation of the accuracy and precision of the CDI 500 in-line blood gas monitor with and without gas calibration
US20120289853A1 (en) System and method for determining dead space fraction in an ongoing manner from intermittent blood gas samples

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11805113

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11805113

Country of ref document: EP

Kind code of ref document: A2